Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Peptidream Inc (4587 JP)
Watchlist
28
Analysis
Health Care
•
Japan
PeptiDream Inc. is a biopharmaceutical company that researches and develops peptide therapeutics to improve the life of patients.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
17 Apr 2017 06:55
The Week That Was in NorthAsia@Smartkarma: Toshiba, Peptidream, and Missiles
It's been a full week for coverage of North Asia on Smartkarma. 30-odd insights on Japan and a dozen on Korea.ToshibaThe big theme of the week, and...
Mio Kato
Follow
357 Views
Share
bullish
•
Medrx Co Ltd
•
16 Apr 2017 18:50
Medrx - Japan Biotech Microcap in Potential Big Licensing Deal
Although the Japanese drug industry suffers from a lack of scale, where it is good is in applying manufacturing techniques to develop not just...
Pelham Smithers Associates
437 Views
Share
bullish
•
Peptidream Inc
•
11 Apr 2017 21:53
PeptiDream: J&J Latest Drug Major to Tie Up
On the surface, Peptidream's (4587 JP) deal with Johnson & Johnson's (JNJ US) Janssen unit looks no different from the deals they have cut with...
Pelham Smithers Associates
345 Views
Share
bullish
•
Kyowa Kirin Co Ltd
•
10 Apr 2017 16:15
Sosei & Kyowa Hakko Kirin: Positive News on GPCR Drugs
Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...
Pelham Smithers Associates
297 Views
Share
bearish
•
Thematic (Sector/Industry)
•
06 Aug 2016 18:07
Death Rattle for Defensives?
While it is not a given that a switch from a high growth, high interest rate environment to a low growth, low interest rate environment is a good...
Pelham Smithers Associates
1k Views
Share
First
Previous
2
3
4
5
6
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x